Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

• Váldodahkkit: A. Minosi (Dahkki), P. Di Giuseppe (Dahkki), L. Serafino (Dahkki), C. Bonali (Dahkki), S. Bello (Dahkki), N. Terlizzi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: PAGEPress Publications, 2011-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective: To evaluate efficacy and safety of intra-articular therapy (IA) with infliximab (IFX), in patients with psoriatic arthritis (PsA) and refractory monoarthritis. Methods: Four male and 1 female aged from 25 to 71 years and disease duration from 1 to 25 years, affected by PsA (CASPAR criteri...